AlphaOnco Swiss SA

AlphaOnco Swiss SA develops a focal therapy for prostate cancer that combines injectable, naturally derived magnetosomes with a low-intensity ultrasound heating module. The company produces the magnetosome suspension and an ultrasound-based heating probe as medical devices and bases its approach on preclinical evidence, publications and patent-protected methods.